Infectious Diseases (except HIV/AIDS)

  1. Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1/2 and phase-2 clinical trials

    1. Subhash Thuluva
    2. Vikram Paradkar
    3. Subba Reddy Gunneri
    4. Vijay Yerroju
    5. Rammohan Mogulla
    6. Kishore Turaga
    7. Mahesh Kyasani
    8. Senthil Kumar Manoharan
    9. Guruprasad Medigeshi
    10. Janmejay Singh
    11. Heena Shaman
    12. Chandramani Singh
    13. Venkateshwar Rao A

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. A systematic review and meta-analysis of Long COVID symptoms

    1. Arun Natarajan
    2. Ashish Shetty
    3. Gayathri Delanerolle
    4. Yutian Zeng
    5. Yingzhe Zhang
    6. Vanessa Raymont
    7. Shanaya Rathod
    8. Sam Halabi
    9. Kathryn Elliot
    10. Peter Phiri
    11. Jian Qing Shi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers

    1. Thomas Theo Brehm
    2. Felix Ullrich
    3. Michelle Thompson
    4. Julia Küchen
    5. Dorothee Schwinge
    6. Anthea Spier
    7. Samuel Huber
    8. Johannes K. Knobloch
    9. Martin Aepfelbacher
    10. Marylyn M. Addo
    11. Ansgar W. Lohse
    12. Marc Lütgehetmann
    13. Julian Schulze zur Wiesch

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Usefulness of real-time RT-PCR to understand the kinetics of SARS-CoV-2 in blood: A prospective study

    1. Nelly Daniela Zurita-Cruz
    2. Alexandra Martín-Ramírez
    3. Diego Aníbal Rodríguez-Serrano
    4. Isidoro González-Álvaro
    5. Emilia Roy-Vallejo
    6. Rafael De la Cámara
    7. Leticia Fontán García-Rodrigo
    8. Laura Cardeñoso-Domingo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. EXPRESSION OF CONCERN: Culture and identification of a “Deltamicron” SARS‐CoV‐2 in a three cases cluster in southern France

    1. Philippe Colson
    2. Pierre‐Edouard Fournier
    3. Jeremy Delerce
    4. Matthieu Million
    5. Marielle Bedotto
    6. Linda Houhamdi
    7. Nouara Yahi
    8. Jeremy Bayette
    9. Anthony Levasseur
    10. Jacques Fantini
    11. Didier Raoult
    12. Bernard La Scola

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis

    1. Rachel Beckerman
    2. Andrea Gori
    3. Sushanth Jeyakumar
    4. Jakob J. Malin
    5. Roger Paredes
    6. Pedro Póvoa
    7. Nathaniel J. Smith
    8. Armando Teixeira-Pinto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host

    1. Sissy Therese Sonnleitner
    2. Martina Prelog
    3. Stefanie Sonnleitner
    4. Eva Hinterbichler
    5. Hannah Halbfurter
    6. Dominik B. C. Kopecky
    7. Giovanni Almanzar
    8. Stephan Koblmüller
    9. Christian Sturmbauer
    10. Leonard Feist
    11. Ralf Horres
    12. Wilfried Posch
    13. Gernot Walder

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Changing Dynamics of COVID-19 Deaths During the SARS-CoV2 B.1.617.2 (Delta Variant) Outbreak in England and Wales: Reduced COVID-19 Deaths Among the Care Home Residents

    1. Venkata R. Emani
    2. Raghunath Reddy
    3. Shaila R. Emani
    4. Kartik K. Goswami
    5. Kailash R. Maddula
    6. Nikhila K. Reddy
    7. Abirath S. Nakka
    8. Nidhi K. Reddy
    9. Dheeraj Nandanoor
    10. Sanjeev Goswami

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  9. Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis

    1. Nicola K Wills
    2. Nikhil Nair
    3. Kashyap Patel
    4. Omaike Sikder
    5. Marguerite Adriaanse
    6. John Eikelboom
    7. Sean Wasserman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

    1. Spyros Chalkias
    2. Howard Schwartz
    3. Biliana Nestorova
    4. Jing Feng
    5. Ying Chang
    6. Honghong Zhou
    7. Frank J. Dutko
    8. Darin K. Edwards
    9. David Montefiori
    10. Rolando Pajon
    11. Brett Leav
    12. Jacqueline M. Miller
    13. Rituparna Das

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 189 of 716 Next